Stay updated on Pembrolizumab for Advanced Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:35:01.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the evaluation of objective response rate (ORR) in patients with advanced uveal melanoma receiving pembrolizumab in a phase II clinical trial.
    Difference
    0.1%
    Check dated 2024-06-06T14:31:57.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to a detailed description of eligibility criteria, explaining that researchers look for participants who meet specific health conditions or prior treatments. The new text also provides an example of such criteria and directs users to 'Learn About Studies' for more information on clinical research.
    Difference
    47%
    Check dated 2024-05-22T21:00:20.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:21:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Advanced Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.